Captrust Financial Advisors Sells 3,716 Shares of The Allstate Co. (NYSE:ALL)

Captrust Financial Advisors lessened its holdings in The Allstate Co. (NYSE:ALL) by 2.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 122,710 shares of the insurance provider’s stock after selling 3,716 shares during the quarter. Captrust Financial Advisors’ holdings in Allstate were worth $23,272,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. BDF Gestion acquired a new position in shares of Allstate during the 2nd quarter worth approximately $3,051,000. OFI Invest Asset Management acquired a new position in Allstate during the second quarter worth $476,000. Diversified Trust Co raised its position in Allstate by 505.3% during the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock worth $1,265,000 after acquiring an additional 6,614 shares in the last quarter. Eagle Asset Management Inc. lifted its stake in Allstate by 38.0% in the third quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock valued at $2,067,000 after acquiring an additional 2,888 shares during the last quarter. Finally, Cetera Investment Advisers grew its position in shares of Allstate by 351.6% in the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock valued at $11,284,000 after acquiring an additional 50,780 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Trading Down 0.4 %

Shares of NYSE:ALL opened at $207.39 on Friday. The business’s 50 day simple moving average is $193.02 and its 200 day simple moving average is $179.10. The Allstate Co. has a 1 year low of $134.17 and a 1 year high of $209.88. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a market capitalization of $54.92 billion, a P/E ratio of 13.43, a P/E/G ratio of 1.83 and a beta of 0.48.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period in the prior year, the firm posted $0.81 EPS. Allstate’s quarterly revenue was up 14.7% on a year-over-year basis. On average, research analysts anticipate that The Allstate Co. will post 16.26 EPS for the current fiscal year.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ALL has been the topic of a number of research analyst reports. UBS Group upped their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Bank of America lifted their target price on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Wells Fargo & Company increased their price target on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Jefferies Financial Group raised their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Piper Sandler upped their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Allstate has an average rating of “Moderate Buy” and a consensus price target of $217.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.